Artificial Pancreas - Pipeline Review, 2015 is a new market research publication announced by Reportstack. This report provides an overview of Artificial Pancreas currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Pancreas pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.
To view the table of contents and know more details, please visit Artificial Pancreas - Pipeline Review, 2015.
- Extensive coverage of the Artificial Pancreas products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Pancreas under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Advanced Biosensors-Ohio, Llc Animas Corporation Beta-O2 Technologies Ltd. Bigfoot Biomedical, Inc. BioTex, Inc. Boston University Cerco Medical Converge Biotech, Inc. Covalor Medical, LLC De Montfort University Defymed Diabeloop Dose Safety Inc. Imperial College London Inreda Diabetic BV Kencak LLC Medtronic plc Miromatrix Medical Inc. Pacific Diabetes Technologies, Inc. Pancreum, LLC PharmaCyte Biotech, Inc. Rensselaer Polytechnic Institute Schneider Children's Medical Center of Israel TecMed, Inc. The University of Newcastle Ultradian Diagnostics LLC Universidad Autonoma de Madrid Universitat Politecnica de Valencia University of California, San Francisco University of California, Santa Barbara University of Cambridge University of Florida University of Virginia ViaCyte, Inc. XERIS Pharmaceuticals, Inc.
Manager - Marketing
Reportstack Market Research